过氧化物通过调节NCOA2介导的PPAR-γ无化和降解来缓解PCOS相关的脂肪生成和胰岛素抵抗
Qi Zhou1, Hong Tang2, Yongfeng Wang2
1Departments of Gynaecology and Obstetrics, The Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai 200137, China; Central Laboratory, The Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, 200137, China.
Life sciences
|January 29, 2025
概括
超酸 (HPS) 通过抑制脂肪生成和调节NCOA2-介导的PPAR-γ无处置来改善多囊性卵巢综合征 (PCOS). 这项研究强调脂肪生成是PCOS发展的关键因素.
科学领域:
- 内分泌学 在内分泌学.
- 代谢障碍 代谢障碍 代谢障碍
- 细胞生物学 细胞生物学
背景情况:
- 多囊卵巢综合征 (PCOS) 与胰岛素抵抗和肥胖等代谢问题有关.
- 脂肪生成在PCOS病理生理学中的特定作用需要进一步阐明.
研究的目的:
- 调查脂肪生成在PCOS发展中的作用.
- 评估高酸盐 (HPS) 作为PCOS治疗中的抗增脂剂.
主要方法:
- 在体内 (PCOS小鼠) 和体外模型中使用.
- 评估了HPS对卵巢功能,胰岛素抵抗和脂肪生成的影响.
- 分析了NCOA2和PPAR-γ通过qPCR和Westernblotting进行的全域化/降解;进行了NCOA2敲击实验.
主要成果:
- 在PCOS小鼠中,HPS治疗改善了卵巢功能,降低了胰岛素耐药性,并抑制了脂肪生成.
- HPS通过降低NCOA2来抑制脂肪生成,防止PPAR-γ的泛化和降解.
- NCOA2 Knockdown证实了其在改善PCOS相关参数方面的作用.
结论:
- 通过调节NCOA2介导的PPAR-γ无化和降解,HPS可以缓解PCOS症状.
- 这些发现为PCOS病理生理学中脂肪生成的作用提供了新的见解.
相关概念视频
Peroxisomes
9.8K
Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...
9.8K
Obesity
371
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
371
Hormonal Control of the Ovarian Cycle
393
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
393
Oral Hypoglycemic Agents: Biguanides and Glitazones
164
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
164
Cholesterol: Significance and Regulation
498
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
498
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
148
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
148


